» Articles » PMID: 9715273

Chromosome Number and Structure Both Are Markedly Stable in RER Colorectal Cancers and Are Not Destabilized by Mutation of P53

Overview
Journal Oncogene
Date 1998 Aug 26
PMID 9715273
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Fourteen colorectal cancer cell lines, categorized according to the presence or absence of microsatellite instability, were further analysed for chromosomal stability by karyotyping. NonRER (microsatellite stable) cell lines typically displayed highly aberrant karyotypes with alterations not only of chromosome number but also of chromosome structure including chromosomal deletions, inversions, and translocations. RER (microsatellite unstable) cell lines, in contrast, displayed significantly fewer alterations of chromosome number. Moreover, RER cell lines also displayed significantly fewer cytogenetically evident alterations of chromosome structure. Compared to NonRER colon cancers, RER colon cancers are significantly less likely to have undergone chromosomal gain, loss, or breakage. Characterization of p53 gene status by gene sequencing was performed in an attempt to determine if p53 gene status correlated with the chromosomal stability of the RER cancers. Gene mutations in p53 were present in all of the NonRER colon cancers. However, p53 gene mutations were also found present in four of nine of the RER colon cancers. Unexpectedly, RER colon cancers bearing mutant p53 demonstrated the same stability of chromosome number, and the same stability of chromosome structure, as the RER colon cancers with wild-type p53. Therefore, in RER colon cancers specific p53 independent mechanisms actively maintain the stability of both chromosome number and structure.

Citing Articles

study of radiosensitivity in colorectal cancer cell lines associated with Lynch syndrome.

Sun M, Moquet J, Barnard S, Mancey H, Burling D, Baldwin-Cleland R Front Public Health. 2024; 12:1369201.

PMID: 38638480 PMC: 11024246. DOI: 10.3389/fpubh.2024.1369201.


Association of a novel point mutation in MSH2 gene with familial multiple primary cancers.

Hu H, Li H, Jiao F, Han T, Zhuo M, Cui J J Hematol Oncol. 2017; 10(1):158.

PMID: 28974240 PMC: 5627420. DOI: 10.1186/s13045-017-0523-y.


Chromosomal Instability in Gastric Cancer Biology.

Saboor Maleki S, Rocken C Neoplasia. 2017; 19(5):412-420.

PMID: 28431273 PMC: 5397576. DOI: 10.1016/j.neo.2017.02.012.


Human MLH1 suppresses the insertion of telomeric sequences at intra-chromosomal sites in telomerase-expressing cells.

Jia P, Chastain M, Zou Y, Her C, Chai W Nucleic Acids Res. 2017; 45(3):1219-1232.

PMID: 28180301 PMC: 5388398. DOI: 10.1093/nar/gkw1170.


Investigating cytokinesis failure as a strategy in cancer therapy.

McKenzie C, DAvino P Oncotarget. 2016; 7(52):87323-87341.

PMID: 27895316 PMC: 5349991. DOI: 10.18632/oncotarget.13556.